Insider Trading July 10, 2026 06:40 PM

Thrivent Financial Reduces Position in Gloo Holdings Amid Market Volatility

The financial services group offloaded nearly half a million dollars in shares as the stock trades near its 52-week low, even as the company pursues a new public offering and receives an upgraded analyst outlook.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
GLOO

Thrivent Financial for Lutherans, a major shareholder holding approximately 10% of Gloo Holdings, Inc., has executed a series of sales totaling roughly $496,025 in Class A Common Stock. The divestment occurred over a three-day window in early July 2026, with the organization selling 158,000 shares across varying price points. This activity coincides with GLOO shares trading near their 52-week low of $2.94, reflecting a significant 33.6% decline over the preceding week. Despite this downward price action, the company is advancing a public offering priced at $3.25 per share for 7 million shares, aiming to raise approximately $22.75 million. Concurrently, Benchmark has raised its price target for GLOO to $15.00, maintaining a Buy rating following the company's strong fiscal first-quarter 2026 results.

Thrivent Financial Reduces Position in Gloo Holdings Amid Market Volatility
GLOO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Thrivent Financial for Lutherans sold 158,000 shares of Gloo Holdings between July 8 and July 10, 2026, reducing its stake while still holding 4,460,000 shares.
  • Gloo Holdings is executing a public offering priced at $3.25 per share for 7 million shares, aiming to raise approximately $22.75 million in gross proceeds.
  • Benchmark raised its price target for GLOO to $15.00 from $14.00, maintaining a Buy rating after the company reported fiscal Q1 2026 results that exceeded expectations.

Thrivent Financial for Lutherans, a prominent financial services organization based in Minneapolis, has reported a significant reduction in its stake within Gloo Holdings, Inc. (GLOO). The entity, which maintains a substantial 10% ownership position in the company, disclosed the sale of approximately $496,025 worth of Class A Common Stock. This transactional activity was documented in a recent filing submitted to the Securities and Exchange Commission, specifically Form 4, and unfolded over a concentrated three-day trading period between July 8 and July 10, 2026.

The divestment involved the liquidation of a total of 158,000 shares. These sales were executed at varying price points, with the per-share cost ranging from $2.978 to $3.9791. The specific breakdown of these transactions reveals a pattern of sales across the three-day window:

  • On July 8, 2026, Thrivent Financial sold 13,000 shares of Class A Common Stock. The execution prices for this portion ranged between $3.880 and $4.110 per share.
  • On July 9, 2026, the largest block of shares was sold, totaling 125,000 shares. The price range for this specific day fell between $3.030 and $3.205 per share.
  • On July 10, 2026, an additional 20,000 shares were sold. The transaction prices for this final day ranged from $2.940 to $3.065 per share.

Following the completion of these transactions, Thrivent Financial for Lutherans continues to hold a direct position of 4,460,000 shares of Gloo Holdings, Inc. Class A Common Stock. The timing of these sales is notable given the current market performance of GLOO shares. The stock is currently trading at $2.95, a level that hovers just above its 52-week low of $2.94. Data from InvestingPro indicates that the stock has experienced a sharp decline of approximately 33.6% over the past week alone.

Despite the recent downward pressure on the stock price, some analytical perspectives suggest that the shares may be undervalued. GLOO appears on the platform’s list of Most Undervalued stocks. For investors seeking more granular data, comprehensive Pro Research Reports and additional ProTips are available through the InvestingPro platform, which hosts over 1,400 such reports.

Parallel to the insider selling activity, Gloo Holdings has announced the pricing of a new public offering. The company has set the offering price at $3.25 per share for a total of 7 million shares of Class A common stock. The gross proceeds from this offering are expected to reach approximately $22.75 million, prior to the deduction of underwriting discounts, commissions, and other associated expenses. Furthermore, the company has granted underwriters a 30-day option to purchase up to an additional 1,050,000 shares. This over-allotment option could potentially increase the total gross proceeds to around $26.16 million.

This public offering follows the company’s recent filing of a registration statement with the Securities and Exchange Commission. In a contrasting move to the stock's recent price weakness, Benchmark has raised its price target for Gloo Holdings to $15.00, up from $14.00, while maintaining a Buy rating. This adjustment comes in the wake of Gloo reporting its fiscal first-quarter 2026 results, which surpassed analyst expectations. The underwriting of this offering is being managed by Citizens Capital Markets and Roth Capital Partners.

The confluence of these events highlights a complex financial landscape for Gloo Holdings. While the company is actively raising capital and receiving positive analyst feedback based on recent earnings, it is simultaneously navigating a period of significant stock price depreciation and reducing its investor base through the sale of substantial holdings by a major owner.

Risks

  • The stock price of GLOO has declined approximately 33.6% over the past week, trading near its 52-week low of $2.94, indicating significant short-term volatility and downward pressure.
  • The public offering will dilute existing shareholders and introduces execution risk, as the company must successfully market 7 million shares to raise the targeted capital.
  • Despite positive analyst ratings, the concurrent selling by a major 10% owner like Thrivent Financial may signal internal caution or liquidity needs, creating uncertainty for market participants regarding the stock's immediate trajectory.

More from Insider Trading

Mineralys Therapeutics CMO Rodman Executes Pre-Arranged Stock Sale and Option Exercise Jul 10, 2026 Taysha Gene Therapies President Executes $1.25 Million Share Sale Under Pre-Approved Plan Jul 10, 2026 Broadcom Director Gayla Delly Disposes of $728,000 in AVGO Shares Amidst Strategic Expansion Jul 10, 2026 Broadcom Legal Officer Executes Nearly $9.5 Million Stock Sale Jul 10, 2026 SRB Corp and Plymouth Rock Co Execute Joint Sale of Safety Insurance Shares Jul 10, 2026